ITGB4 and neoplasm: In breast cancer, ZEB1 represses the expression of the epithelial transcription factor TAp63α (tumor protein 63 isoform 1) and promotes ITGB4 (also known as CD104) expression, which allows the cells to present as tumor-initiating cells.